These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11846243)

  • 1. Medication update.
    Slagle M
    South Med J; 2002 Feb; 95(2):188-91. PubMed ID: 11846243
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary incontinence--treatment].
    Hader C; Welz-Barth A; Keller T
    Dtsch Med Wochenschr; 2003 Apr; 128(14):750-2. PubMed ID: 12673531
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticholinergic drugs for overactive bladder.
    Kripke C
    Am Fam Physician; 2006 Jan; 73(1):66. PubMed ID: 16417066
    [No Abstract]   [Full Text] [Related]  

  • 4. Enuresis.
    Cossio SE
    South Med J; 2002 Feb; 95(2):183-7. PubMed ID: 11846242
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical treatment of overactive bladder.
    Rackley R; Wein A; Nelson D
    Mayo Clin Proc; 2001 Nov; 76(11):1179-80. PubMed ID: 11702910
    [No Abstract]   [Full Text] [Related]  

  • 6. New treatment options for overactive bladder and incontinence.
    Newman DK
    Director; 2002; 10(3):74-6. PubMed ID: 12116753
    [No Abstract]   [Full Text] [Related]  

  • 7. Is extended-release oxybutynin (Ditropan XL) or tolterodine (Detrol) more effective in the treatment of an overactive bladder?
    Hartnett NM; Saver BG
    J Fam Pract; 2001 Jul; 50(7):571. PubMed ID: 11485700
    [No Abstract]   [Full Text] [Related]  

  • 8. Achieving bladder control. Treatment in the primary care setting.
    Maloney CM; Cafiero M
    Adv Nurse Pract; 2002 May; 10(5):73-8. PubMed ID: 12420535
    [No Abstract]   [Full Text] [Related]  

  • 9. [Less disability in daily activities].
    Krankenpfl J; 2005; 43(7-10):191. PubMed ID: 16515263
    [No Abstract]   [Full Text] [Related]  

  • 10. RE: Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence.
    Ellsworth P
    J Urol; 2003 Sep; 170(3):928; author reply 928. PubMed ID: 12913741
    [No Abstract]   [Full Text] [Related]  

  • 11. Overactive bladder: evaluation and management in primary care.
    Rosenberg MT; Dmochowski RR
    Cleve Clin J Med; 2005 Feb; 72(2):149-56. PubMed ID: 15757170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatments for overactive bladder.
    Newton M; Kosier JH; Smith D
    Urol Nurs; 2000 Aug; 20(4):267-8. PubMed ID: 11998091
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of overactive bladder: selective use of anticholinergic agents with low drug-drug interaction potential.
    Chancellor MB; de Miguel F
    Geriatrics; 2007 May; 62(5):15-24. PubMed ID: 17489643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of the overactive bladder and advances in drug delivery.
    Cannon TW; Chancellor MB
    Clin Obstet Gynecol; 2002 Mar; 45(1):205-17. PubMed ID: 11862073
    [No Abstract]   [Full Text] [Related]  

  • 15. Detrol LA and Diropan XL for overactive bladder.
    Med Lett Drugs Ther; 2001 Apr; 43(1101):28. PubMed ID: 11283473
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of overactive bladder: the Antimuscarinic Clinical Effectiveness Trial.
    Appell RA
    Curr Urol Rep; 2002 Oct; 3(5):343-4. PubMed ID: 12354340
    [No Abstract]   [Full Text] [Related]  

  • 17. Advancements in pharmacologic management of the overactive bladder.
    Dmochowski RR; Appell RA
    Urology; 2000 Dec; 56(6 Suppl 1):41-9. PubMed ID: 11114562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern pharmacotherapy of urge urinary incontinence in the USA: tolterodine and oxybutynin.
    Rovner ES; Wein AJ
    BJU Int; 2000 Oct; 86 Suppl 2():44-53; discussion 53-4. PubMed ID: 11501617
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment.
    de Jong TP
    J Urol; 2009 Oct; 182(4 Suppl):2038; discussion 2039. PubMed ID: 19695627
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment.
    Jorgensen TM
    J Urol; 2009 Oct; 182(4 Suppl):2038; discussion 2039. PubMed ID: 19695626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.